In the absence of an approved treatment for COVID-19, in March the FDA began allowing researchers to request emergency authorization for the use of convalescent plasma which shows potential as a treatment for the disease.
Researchers at the UC College of Medicine are among those who joined the Mayo Clinic protocol for investigating convalescent plasma as a possible treatment for COVID-19. Convalescent plasma is obtained from people who have recovered from COVID-19 and have been free of symptoms for 28 days. This program may allow access to that plasma for hospitalized patients infected with the novel coronavirus who have severe or life-threatening COVID-19, or who may be at high risk for progression to severe or life-threatening disease.
This research garnered coverage from the Cincinnati Business Courier, Cincinnati Enquirer, WLWT, Fox19 and WVXU.
Featured image at top from freestocks on Unsplash.